Medicamen Biotech has received an ANVISA Brazil approval for Non Beta Lactum solid tablets and coated tablets manufactured at its plant situated at Bhiwadi in Rajasthan vide resolution 5397 No RE of December 02, 2011, officially published in the gazzatte on December 05, 2011 valid for 2 years.
Medicamen Biotech manufactures pharmaceutical formulations for the Indian and overseas markets. Its product range consists of antibiotics, anti-fungicides, anti-diabetics, anti-tuberculosis, tranquillisers, laxatives, anti-asthmatics, and anti-depressants.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: